Inexpensive LAMP-Based Schistosomiasis Tests Developed
By LabMedica International staff writers Posted on 12 Nov 2019 |

Image: The hand-held Genie III scanner has a two-color fluorescence excitation and detection system (Photo courtesy of OPTIGENE Ltd).
Schistosomiasis is one of the most prevalent Neglected Tropical Diseases, affecting approximately 250 million people worldwide. Schistosoma mansoni is the most important species causing human intestinal schistosomiasis.
Several polymerase chain reaction (PCR)-based molecular approaches, including conventional PCR (cPCR), real-time quantitative PCR (qPCR), droplet digital PCR (ddPCR), have been proven effective in detection of schistosome-derived DNA with more sensitivity than parasitological and serological methods, especially in chronic infections and in low transmission areas.
Scientists at the University of Salamanca (Salamanca, Spain) originally developed a loop-mediated isothermal amplification (LAMP) method for the detection of S. mansoni DNA (SmMIT-LAMP). They have now developed an important improvement for SmMIT-LAMP molecular assay, transforming it into a cold maintenance dry format suitable for potentially manufacturing as kit for ready-to-use for schistosomiasis diagnosis.
DNA from three patients’ tissue samples with microscopy-confirmed infection with S. mansoni was tested by LAMP including cutaneous and hepatic biopsies and an appendix biopsy. DNA was isolated from tissue samples using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). The real-time SmMIT-LAMP reactions were performed in 8-tube Genie Strips on a portable Genie III device (OPTIGENE Ltd., Horsham, UK) at 65 °C for 60 minutes followed up by 10 minutes at 80 °C. Amplicons were confirmed on 1.5% agarose gels when required.
The team reported that endpoint results at 65–70 minutes (counting 60 minutes for reaction plus 5–10 minutes of inactivation) were clearly observed with naked eye by adding the fluorescent dye SYBR Green I post-amplification. The positive LAMP reactions turned to green; otherwise, they remained orange. Correlation of positive colorimetric results with the typical ladder of multiple bands on agarose gels was clear.
Real-time SmMIT-LAMP was carried out on a portable device using the same reaction conditions, but testing including or not betaine in the master mix. Real-time reactions worked properly in both cases and a strong correlation between the signal of the fluorescent EvaGreen dye and electrophoresis was obtained. However, removing betaine from the mixture resulted on a 10 minute reduction in the amplification time while showing identical intensity of electrophoresis bands. Both fresh and desiccated SmMIT-LAMP mixtures yielded amplification signals for S. mansoni-positive control and tissue samples. Nevertheless, a delay in the appearance of positive results and a decrease in the fluorescence signals were observed when using desiccated mixtures.
The authors concluded that the one-step dry-up protocol is simpler and faster than those previously reported and allows maintaining the functionality for at least three weeks at RT and up to five months at 4 °C. Their work demonstrated an important improvement for SmMIT-LAMP molecular assay, transformed into a cold maintenance dry format suitable for manufacturing as kit for ready-to-use for S. mansoni DNA detection. The study was published on October 14, 2019 in the journal Scientific Reports.
Related Links:
University of Salamanca
QIAGEN
OPTIGENE Ltd
Several polymerase chain reaction (PCR)-based molecular approaches, including conventional PCR (cPCR), real-time quantitative PCR (qPCR), droplet digital PCR (ddPCR), have been proven effective in detection of schistosome-derived DNA with more sensitivity than parasitological and serological methods, especially in chronic infections and in low transmission areas.
Scientists at the University of Salamanca (Salamanca, Spain) originally developed a loop-mediated isothermal amplification (LAMP) method for the detection of S. mansoni DNA (SmMIT-LAMP). They have now developed an important improvement for SmMIT-LAMP molecular assay, transforming it into a cold maintenance dry format suitable for potentially manufacturing as kit for ready-to-use for schistosomiasis diagnosis.
DNA from three patients’ tissue samples with microscopy-confirmed infection with S. mansoni was tested by LAMP including cutaneous and hepatic biopsies and an appendix biopsy. DNA was isolated from tissue samples using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). The real-time SmMIT-LAMP reactions were performed in 8-tube Genie Strips on a portable Genie III device (OPTIGENE Ltd., Horsham, UK) at 65 °C for 60 minutes followed up by 10 minutes at 80 °C. Amplicons were confirmed on 1.5% agarose gels when required.
The team reported that endpoint results at 65–70 minutes (counting 60 minutes for reaction plus 5–10 minutes of inactivation) were clearly observed with naked eye by adding the fluorescent dye SYBR Green I post-amplification. The positive LAMP reactions turned to green; otherwise, they remained orange. Correlation of positive colorimetric results with the typical ladder of multiple bands on agarose gels was clear.
Real-time SmMIT-LAMP was carried out on a portable device using the same reaction conditions, but testing including or not betaine in the master mix. Real-time reactions worked properly in both cases and a strong correlation between the signal of the fluorescent EvaGreen dye and electrophoresis was obtained. However, removing betaine from the mixture resulted on a 10 minute reduction in the amplification time while showing identical intensity of electrophoresis bands. Both fresh and desiccated SmMIT-LAMP mixtures yielded amplification signals for S. mansoni-positive control and tissue samples. Nevertheless, a delay in the appearance of positive results and a decrease in the fluorescence signals were observed when using desiccated mixtures.
The authors concluded that the one-step dry-up protocol is simpler and faster than those previously reported and allows maintaining the functionality for at least three weeks at RT and up to five months at 4 °C. Their work demonstrated an important improvement for SmMIT-LAMP molecular assay, transformed into a cold maintenance dry format suitable for manufacturing as kit for ready-to-use for S. mansoni DNA detection. The study was published on October 14, 2019 in the journal Scientific Reports.
Related Links:
University of Salamanca
QIAGEN
OPTIGENE Ltd
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more